Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 13 February 2017 |
| Author/s |
author: Cem Meydan Christopher E. Mason Andrew Intlekofer Craig B. Thompson |
| Publication date | February 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |